Skip to main content

Table 1 Patient characteristics and results of brachial artery flow-mediated dilation test

From: Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan

No. Age Gender Prior treatment Give up smoking Months F/u Pre-treatment clinical results Post-treatment clinical results BAFMD Pre-treatment BAFMD Post-treatment BAFMD 3 months after
1 35 F PG + LS YES 20 Ulcer in toe Healing 1.1 6.7 11.6
2 36 F PG YES 40 Ulcer in toes Healing 0 5.2 17.1
3 32 M PG NO 21 Ulcer in fingers Healing 1.5 6.9 10.8
4 46 F PG NO 20 Ulcer in fingers Healing 0.8 6.5 12.3
5 47 M PG NO 12 Pain at rest Pain relief Claudicates 300 m 2.3 7.1 12.6
6 46 M PG NO 11 Ulcer in toes Healing 3.5 8.9 9.8
7 29 M PG NO 35 Ulcer in toes Healing 1.2 4.1 9.6
8 39 F BP (occlude) NO 31 Ulcer in toe Healing 0.3 5.9 11.3
9 45 M BP (occlude) NO 18 Ulcer in toe Ulcer Improvement 0.9 4.9 10.1
10 39 F PG + LS YES 16 Ulcer in forefoot ICA 3.7 7.7 16.9
11 22 M PG + LS NO 13 Ulcer in toes Healing. Amp. 3rd toe 4.1 7.8 17.9
12.a 49 M 2 BP (permeable) + PG YES 12 Ulcer in toe Healing 2.3 6.9 12.3
12.b 49 M PG YES 12 Ulcer in fingers Ulcer Improvement 2.3 6.9 12.3
  1. Abbreviations: BAFMD: brachial artery flow-mediated dilation test; ICA: Infracondylar amputation; Amp: Amputation; BP: Bypass; F: Female; M: Male; PG: Prostaglandins; LS: Lumbar Sympathectomy; F/u: follow-up.